Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology
- 1 February 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in Population Health Management
- Vol. 26 (1), 29-36
- https://doi.org/10.1089/pop.2022.0241
Abstract
Individuals at increased risk for severe coronavirus disease-2019 (COVID-19) outcomes, due to compromised immunity or other risk factors, would benefit from objective measures of vulnerability to infection based on vaccination or prior infection. The authors reviewed published data to identify a specific role and interpretation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike-targeted serology testing. Specific recommendations are provided for an evidence-based and clinically-useful interpretation of SARS-CoV-2 spike-targeted serology to identify vulnerability to infection and potential subsequent adverse outcomes. Decreased vaccine effectiveness among immunocompromised individuals is linked to correspondingly high rates of breakthrough infections. Negative results on SARS-CoV-2 antibody tests are associated with increased risk for subsequent infection. “Low-positive” results on semiquantitative SARS-CoV-2 spike-targeted antibody tests may help identify persons at increased risk as well. Standardized SARS-CoV-2 spike-targeted antibody tests may provide objective information on the risk of SARS-CoV-2 infection and associated adverse outcomes. This holds especially for high-risk populations that demonstrate a relatively high rate of seronegativity. The widespread availability of such tests presents an opportunity to refine risk assessment for individuals with suboptimal SARS-CoV-2 antibody levels and to promote effective interventions. Interim federal guidance would support physicians and patients while additional investigations are pursued.Keywords
This publication has 47 references indexed in Scilit:
- Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future InfectionJAMA Internal Medicine, 2021
- The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19Acta Diabetologica, 2021
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersThe New England Journal of Medicine, 2021
- Decline and loss of anti–SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infectionKidney International, 2021
- Protection of Healthcare Workers Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) ReinfectionClinical Infectious Diseases, 2021
- SARS-CoV-2 Serologic Assay Needs for the Next Phase of the US COVID-19 Pandemic ResponseOpen Forum Infectious Diseases, 2020
- Factors associated with COVID-19-related death using OpenSAFELYNature, 2020
- Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious eventsDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical VentilationObesity, 2020
- Changes in Nutritional Status Impact Immune Cell Metabolism and FunctionFrontiers in Immunology, 2018